The US Food and Drug Administration (FDA) approved a new oral antibiotic to treat uncomplicated urinary tract infections ...

The Food and Drug Administration has approved Iterum Therapeutics' Orlynvah, the first drug of its kind, which is designed to ...

Get detailed information on Probenecid, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated prescription ...

Probenecid is an alkalizer. It is used in the treatment of gout. It works by making the urine less acidic and helps the ...

The FDA approved oral sulopenem etzadroxil and probenecid (Orlynvah) to treat uncomplicated urinary tract infections (uUTIs) caused by certain bacteria in women with limited or no alternative oral ...

Probenecid 500mg, colchicine 0.5mg; scored tabs. History of peptic ulcer. Spastic colon. GI, renal, hepatic, or hematological disorders. G6PD deficiency. Monitor ...

Orlynvah combines sulopenem etzadroxil, a penem antibacterial drug, and probenecid, a renal tubular inhibitor, in a bilayer tablet. The treatment has been shown to be active against third generation ...

Orlynvah is the first oral penem approved in the U.S. and Iterum Therapeutics’ first FDA-approved product. CEO Corey Fishman ...

The opioid addiction treatment market will be worth $2.4bn by 2033, driven by diagnoses in the eight major world markets.

Iterum Therapeutics' Orlynvah receives FDA approval for treating uncomplicated UTIs in adult women, marking its first ...

Review the side-effects of Probenecid as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of ...

GSK acquired an experimental therapy from Chimagen Biosciences, paying $300 million upfront for the “T-cell engager” therapy, ...